Ntf3 — Neurotrophin 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
**Gene Symbol:** NTF3
**Full Name:** Neurotrophin-3
**Chromosomal Location:** 12p13.31
**NCBI Gene ID:** 4902
**OMIM:** 162660
**Ensembl ID:** ENSG00000185652
**UniProt:** P20783 (NT3_HUMAN)
**Associated Diseases:** Alzheimer's Disease, Peripheral Neuropathy, Multiple Sclerosis
NTF3 (Neurotrophin-3) is a member of the neurotrophin family that supports the development and survival of specific neuronal populations.
Neurotrophin-3 (NT-3) is a member of the neurotrophin family of growth factors, which includes NGF, BDNF, and NT-4. NT-3 is unique among neurotrophins because it can bind to all Trk receptors (TrkA, TrkB, and TrkC), although it has highest affinity for TrkC.
NT-3 binds to:
NT-3 is widely expressed in:
NT-3 is essential for:
NT-3 plays important roles in:
Therapeutic potential: NT-3 delivery may support cholinergic function in AD. AAV-NT3 gene therapy is in preclinical development.
NT-3 is critical for:
Clinical trials: NT-3 has been tested in clinical trials for diabetic peripheral neuropathy with some positive results.
NT-3 may promote:
| Approach | Status | Description |
|---|---|---|
| Recombinant NT-3 | Clinical trials | Protein delivery for peripheral neuropathy |
| AAV-NT3 gene therapy | Preclinical | Viral vector delivery |
| Small molecule TrkC agonists | Preclinical | Oral bioavailability |
NTF3 has been investigated for its regenerative properties in various neurological conditions:
NTF3 promotes axonal regeneration and functional recovery following spinal cord injury. Combined approaches with Schwann cell transplantation have shown enhanced neural regeneration in preclinical models.
NTF3 supports peripheral nerve repair and has been used in combination with nerve guidance conduits to enhance axonal growth across injury sites.
NTF3 is being investigated for its potential to promote regeneration of auditory neurons in sensorineural hearing loss.
NTF3 exhibits cross-reactivity with neurotrophin receptors:
This broad receptor binding profile makes NTF3 a versatile therapeutic candidate for targeting multiple neuronal populations simultaneously.
The study of Ntf3 — Neurotrophin 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.